This article has Open Peer Review reports available.
Tracheal replacement by autogenous aorta
© Anoosh et al; licensee BioMed Central Ltd. 2009
Received: 15 March 2009
Accepted: 09 June 2009
Published: 09 June 2009
Tracheal defects may occur after trauma or prolonged intubation. Resection of tracheal tumors also poses a major challenge for substitution. In an effort to solve this problem, different techniques have been tried with little success. We report on a new animal model which showed acceptable results with fewer complications.
We replaced 5 cm of cervical trachea in 10 dogs with harvested infra-renal aorta and repaired the aortic defect with Dacron graft.
Necropsy of the grafted aorta and anastomotic site revealed well healed anastomosis in all animals together with ciliated columnar epithelium coverage of grafted aorta and neovascularization of aortic wall.
Aortic graft is preferable to other substitutes because of less antigenicity, less vascularity, and no mucous secretions or peristalsis
Tracheal defects may occur after trauma or prolonged intubation. Resection of tracheal tumors also poses a major challenge for substitution. In an effort to solve this problem, different techniques have been tried with little success. The various tracheal substitutes and techniques of reconstruction were analyzed by Grillo , who classified them in five categories: foreign materials, nonviable tissues, autogenous tissues, tissue engineering, and tracheal transplantation. Attempts with foreign materials led to problems of chronic infection, airway obstruction, migration of the prosthesis, erosion of major blood vessels and proliferation of granulation tissue. Implantation of nonviable tissues, either chemically treated, frozen or lyophilized has been associated with poorly functional results. Reconstructions with autogenous tissues such as skin, fascia lata, pericardium, costal cartilage, bladder, esophagus or bowel are complex procedures, which have been associated with disappointing results. More recently, efforts have been made to induce the formation of cartilaginous tubes covered with epithelial cells, but to date this type of tissue engineering has not provided reliable results. Finally, tracheal allotransplantation has been also disappointing so far due to complication of necrosis or stenosis of the graft. In addition immunosuppressive therapy does not permit a clinical application in the treatment of cancer. As Grillo suggested: "We must continue to maintain an open mind about this intriguing but thus far unsolved surgical dilemma – replacement of the tracheal conduit" . Recently, Martinod and colleges have used autogenic aortic graft [3, 4] and allogenic Aortic grafts  to replace long segments of tracheal defect and Carina  using sheep as animal model with promising results. Seguin and colleges have used cryopreserved, decellularized aortic allograft supported by temporary stent to prevent airway collapse . We report on a new animal model, which showed acceptable results with few complications.
Eleven healthy dogs ranging from 18 kg to 24 kg in weight were studied. All animals received care in compliance with the "Guide for the care and use of laboratory animals" prepared by the Institute of laboratory animal resources, National research Council, and published by the National Academy Press, revised 1996. Five centimeter of cervical trachea was resected and replaced by harvested abdominal aorta. The aortic defect was repaired with Dacron graft.
General anesthesia was induced with thiopental and maintained with oxygen and 1–3% halothane through an endotracheal tube. All animals were perfused with a crystalloid solution. Pulse were monitored Introperatively. One gram of Cephazoline was injected after the induction of general anesthesia for wound prophylaxis.
In post operative day one diet started for the animals and advanced. Clinical examination was performed daily for fist two week post op and then every month including overall status, weight, respiratory status and injury to the laryngeal nerve. Because none of the animals developed respiratory problems or fever and there was not stent, bronchoscopy and chest X-ray was not performed in the post operative period.
Animals were sacrificed between two and six months after the procedure with intravenous injection of potassium chloride and Propofol to remove the grafts. En block resection of the trachea and the graft with surrounding tissues was performed and sent for macroscopic and microscopic examinations. Post mortem specimens were immediately placed in 10% formaldehyde solution for preservation. The specimens were evaluated for patency, microscopic evidence of inflammation and morphologic transformation of the graft.
Ten animals survived the procedure. The average operative time was 105 minutes. Between 4 to 5 tracheal rings removed in each case. One dog died 4 hours after the operation secondary to heart failure. All the animals started on diet the first post operative day. All abdominal wounds healed primarily. There was one cervical wound infection, which was healed with secondary intention. There was no clinical respiratory problem, cough or pneumonia. There was no evidence of hoarseness and all of the animals start barking a few days after the operation. There was no complication related to aortic Dacron graft. None of the animals developed claudication.
Follow up, complications, functional status and histological examination of specimens
Studies on prosthesis for repairing the tracheal defects have a long history beginning with Daniel's experiment in 1948. Since then, a variety of prosthesis has been used, but the results have been disappointing in a significant proportion of cases. In an extensive analysis of the literature, Grillo [1, 8] underlined the main technical difficulties and complications associated with the current surgical approaches to tracheal replacement in five categories: foreign materials , nonviable tissues [10–12], autogenous tissues [13–16], tissue engineering , and tracheal transplantation. Complications associated with prosthetic grafts were mostly related to lack of biocompatibility and included local infection, anastomotic dehiscence, vascular erosion, granulomatous lesions, and stenosis. Complications associated with biologic tissues were related to the ischemic injury of the harvested graft leading to necrosis or stenosis. None of the proposed tracheal substitutes has produced consistent results that would standardize a clinical approach. Vascularized autografts such as pectoralis muscle, esophagus, and jejunum have shown promising experimental results when used alone, but it is unlikely that the soft tissue alone could provide adequate long-term structural support to maintain a patent airway. Composite implants consisting of a revascularized jejunal autografts in combination with a permanent rigid implantation stent have been utilized in a canine model with promising result. Cryopreserved autografts have been performed, first by Tojo et al. on rats and then by Jacops et al. on pediatric allograft. In both instances, it was found that cryopreservation reduced the antigenicity of the transplants. Martinod and associates have used aortic autograft and allograft with temporary stenting in sheep with promising results. They have reported the tissue transformation using aortic graft. Their findings raise the question of how the aortic tissue can transform into an almost normal trachea within 6 months, with the hypothesis that the inflammatory response created favorable conditions for reepithelialization and subsequent cartilage neoformation from stem cells triggered by environmental factors. Their study also shows a progressive transformation of the vascular graft into a structure resembling the tracheal tissue. This transformation was responsible for the long-term patency of the trachea and its normal function up to 3 years.
In our study, the aorta as an autogenous tissue was used to replace the trachea in a dog model. Surgical techniques for aortic segment excision and Dacron replacement with aortotracheal graft are not complicated and feasible to be done in one stage. Secondly, the aorta has no autogenous immunity-related problems and its diameter in human is comparable to the trachea. Furthermore it provides a sufficient diameter for airway patency. Due to disparity between tracheal and the aortic diameter in dogs, the aorta was transplanted to the proximal and distal tracheal and posterior membranous parts, but it appears that no such disparity is anticipated in humans. The gross and microscopic study of transplanted aortic segment showed neovascularization from adjacent tissues providing a good and resistant grafted tissue without vascular pedicle. The growth of endothelial ciliated cells over the grafted aortic segment lumen without mucous secretion and luminal stenosis is another positive point for this method in comparison with other tubular grafts such as esophagus, jejunum and collagen-conjugated mesh
In conclusion, this study confirms that an autogenous aortic graft is a valuable substitute for tracheal replacement because of less antigenicity, less vascularity, and no mucous secretions or peristalsis. It also shows a progressive transformation of the vascular graft into a structure resembling the tracheal tissue. We did not have any aortic surgery related complications in our study, but it may subject the patient to potential complications of aortic surgery. The use of an arterial allograft may be more practical in human, but it remains to be demonstrated that the same tracheal neogenesis and the same long-term function can be obtained in spite of the allogeneic nature of the graft.
The authors are thankful to Vice Chancellor of research Shiraz University Medical Science for approving and funding the study and personnel of animal lab at Shiraz University Medical Science for their assistance in the study.
- Grillo HC: Tracheal replacement. Surgery of the trachea and bronchi. Edited by: Grillo HC. 2004, BC Decker Inc, Hamilton, 839-54.Google Scholar
- Grillo HC: Tracheal replacement. Ann Thorac Surg. 1990, 49: 864-865.View ArticlePubMedGoogle Scholar
- Martinod E, Zegdi R, Zakine G, Aupecle B, Fornes P, D'audiffret A: A novel approach to tracheal replacement: the use of an aortic graft. J Thorac Cardiovasc Surg. 2001, 122: 197-8. 10.1067/mtc.2001.114346.View ArticlePubMedGoogle Scholar
- Martinod E, Seguin A, Pfeuty K, Fones P, Kambouchner M, Azorine JF, Carpentier AF: Long-term evaluation of the replacement of the trachea with an autologous aortic graft. Ann Thorac Surg. 2003, 75: 1572-8. 10.1016/S0003-4975(03)00120-6.View ArticlePubMedGoogle Scholar
- Martinod E, Seguin A, Holder-Espinasse M, Kambouchner M, Duterque-Coquillaud M, Azorine JF, Carpentier AF: Tracheal regeneration following tracheal replacement with an allogenic aorta. Ann Thorac Surg. 2005, 79: 942-9. 10.1016/j.athoracsur.2004.08.035.View ArticlePubMedGoogle Scholar
- Seguin A, Martinod E, Kambouchner M, Campo G, Dhote P, Bruneval P, Azorin JF, Carpentier AF: Carinal replacement with aortic allograft. Ann Thorac Surg. 2006, 81: 1068-75. 10.1016/j.athoracsur.2005.07.079.View ArticlePubMedGoogle Scholar
- Seguin A, Radu D, Holder-Espinasse M, Bruneval P, Fialaire-legendre A, Duterque-Coquillaud M, Carpentier A, Martinod E: Tracheal replacement with cryopreserved, decellularized, or glutaraldehyde-Treated Aortic Allografts. Ann Thorac Surg. 2009, 87: 861-867. 10.1016/j.athoracsur.2008.11.038.View ArticlePubMedGoogle Scholar
- Grillo HC: Primary tracheal neoplasms. Surgery of the trachea and bronchi. Edited by: Grillo HC. 2004, BC Decker Inc, Hamilton, 207-47.Google Scholar
- Cull DL, Lally KP, Mair EA, Daidone M, Parsons DS: Tracheal reconstruction with polytetrafluoroethylene graft in dogs. Ann Thorac Surg. 1990, 50: 899-901.View ArticlePubMedGoogle Scholar
- Tofo T, Kitamura S, Gojo S, Kushibe K, Nezu K, Taniguchi S: Epithelial regeneration and preservation of tracheal cartilage after tracheal replacement with cryopreserved allograft in the rat. J Thorac Cardiovasc Surg. 1998, 116 (4): 624-7. 10.1016/S0022-5223(98)70169-2.View ArticleGoogle Scholar
- Williams P, Warwick R, Lawrence MD, Bannister H: Gray's anatomy angiology P. 726, Splangiology P. 766. The trachea P. 1259. 1989, seventhGoogle Scholar
- Okumura N, Nakamura T, Nastume T, Tomihata K, Ikada Y, Shimizu Y: Experimental study on a near tracheal prosthesis made from collagen conjugated thorax. Cardiovasc Surgery. 1994, 108 (A): 337-45.Google Scholar
- Sabas AA, Uez JB, Rojas O, Inones A, Aranguren JA: Replacement of the trachea with dura matter. J Thorac Cardiovascular Surg. 1977, 74 (5): 761-764.Google Scholar
- Fleisber A, Khafif R: Reconstruction of the mediastinal trachea with a tube pectoralis major mayocutaneous flap. Plast Reconstr Sur. 1989, 84: 342-6.View ArticleGoogle Scholar
- Kato R, Onuki AS, Watanabe N, Hashizumi T, Kawamura M, Kikuchi K, Kobayashi K, Ishihara T: Tracheal reconstruction by esophageal interposition. Ann Thorac Surg. 1990, 49: 951-954.View ArticlePubMedGoogle Scholar
- Costantino MD, Nus DW, Synderman Ch, Johnson JT, Freidman CD, Narayanan K, Glen Houston C: Experimental tracheal replacement using a revascularized jejunal autograft with an implantable Dacron mesh tube. Ann Otol Rhinol Laryngol. 1992, 101 (10): 807-814.View ArticlePubMedGoogle Scholar
- Vacanti CA, Paige KT, Kim WS, Sakata J, Upton J, Vacani JP: Tracheal replacement using tissue engineered cartilage. J pediatr Surg. 1994, 29 (2): 201-4. 10.1016/0022-3468(94)90318-2.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.